MIKA Pharma

Speyer, Germany Founded: 1994 • Age: 32 yrs Acquired By Giulianipharma
Liposomal non-invasive drug delivery technologies are developed by German biotech.

About MIKA Pharma

MIKA Pharma is a Healthcare company based in Speyer (Germany) founded in 1994, and was acquired by Giulianipharma in March 2010. Liposomal non-invasive drug delivery technologies are developed by German biotech. Its focus areas include Life Sciences, Neurology, Drugs and Pain. Its legal entity is MIKA Pharma GmbH.

Company details

MIKA Pharma was established in 1994 in Speyer, Germany, within the biotech sector. Existing approved drug molecules are reformulated into liposomal non-invasive formats, such as transdermal and transmucosal applications. Transdermal versions of analgesics like Diclofenac and Ketoprofen have been commercialized. Heparin spray-gel, corticosteroid spray-gels, and buccal analgesic sprays have also been produced for targeted delivery.

  • Headquarters Speyer, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mika-pharma.de
  • Social LinkedIn
  • Acquired by Giulianipharma (Mar 2010)
  • Legal Name Mika Pharma Gmbh
Key Metrics

Investors in MIKA Pharma

MIKA Pharma has secured backing from 1 investor. Prominent investors backing the company include Giulianipharma.

All
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical and dermocosmetic products are developed for health solutions.
giulianipharma.comVimodrone, Italy
Premium access

Investor details for MIKA Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of MIKA Pharma

2 dated milestones of MIKA Pharma across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded MIKA Pharma is founded.
  2. Exit Acquired by Giulianipharma.

Web traffic of MIKA Pharma

Websites that share an audience with MIKA Pharma (mika-pharma.de).

Similar websites

Websites whose visitors overlap most with MIKA Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
jutapharma.de
100%
9.4K#2,046,082View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MIKA Pharma

MIKA Pharma was founded in 1994.

MIKA Pharma is headquartered in Speyer, Germany. It is registered at Speyer, Rheinland-pfalz, Germany.

MIKA Pharma was established in 1994 in Speyer, Germany, within the biotech sector. Existing approved drug molecules are reformulated into liposomal non-invasive formats, such as transdermal and transmucosal applications. Transdermal versions of analgesics like Diclofenac and Ketoprofen have been commercialized. Heparin spray-gel, corticosteroid spray-gels, and buccal analgesic sprays have also been produced for targeted delivery.

MIKA Pharma has 1 investor. Key investors include Giulianipharma.

MIKA Pharma operates through Mika Pharma Gmbh.

Yes. MIKA Pharma was acquired by Giulianipharma in March 2010.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available